Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Clasificación en acciones #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Precio por acción
$4.00
Última sincronización: 2026-08-20
Capitalización bursátil
$75.37M
Cambio (1 día)
0.00%
Cambio (1 año)
12.99%
País
US
Comercio RetinalGenix Technologies Inc. (RTGN)

Categoría

EPS de RetinalGenix Technologies Inc. (RTGN)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de RetinalGenix Technologies Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de RetinalGenix Technologies Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$3.11 -
US
$9.73 -
US
$3.59 -
IE
$2.48 -
US
- -
DE